HK Stock Market Move | XTALPI (02228) rises over 5% as XtalPi Science outperforms Claude on multiple drug discovery tasks.

XTALPI (02228) rose over 5%, up 4.3% as of press time, at HK$8.86, with a turnover of HK$731 million. On the news front, XtalPi Science recently announced that its scientific intelligent agent platform XtalPi Science has completed a major product upgrade, officially launching over 80 proprietary scientific skills and tools, and further expanding the scope of invited testing. Testing showed that the platform outperformed Claude in multiple internal drug discovery tasks. Since the beginning of this year, scientific research has become an important area for the accelerated deployment of AI agents, following programming. This trend is also rapidly extending to real experimental processes. Anthropic recently built a wet lab and is exploring having Claude dispatch Siasun Robot&Automation to execute experiments, promoting further integration of intelligent agents with experimental systems. In the first half of the year, the company's AI4S smart solutions grew rapidly and gradually became a core growth engine. Revenue from AI4S smart solutions was RMB 194 million, a year-on-year increase of 136.4%, with its revenue share rising from 15.8% in the same period last year to 49.2%, among which intelligent Siasun Robot&Automation laboratories and intelligent services both maintained rapid growth. Guosheng believes that the company has now formed a full-stack AI4S system integrating scientific intelligent agents, computational models, automated laboratories, and data feedback, and is advancing commercialization in scenarios such as drug discovery and new materials, with the platform's value beginning to shift from technical validation to large-scale realization.